மூளை ஆராய்ச்சி மையங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BrainStorm Issues 2020 Letter to Shareholders
USA - English
Share this article
Share this article
NEW YORK, Dec. 28, 2020 /PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI),  a leading developer of cellular therapies for neurodegenerative diseases, today announced the following letter from its Chief Executive Officer, Chaim Lebovits, to its shareholders and the investment community.
Dear Valued Shareholders,
I am incredibly proud of the tremendous progress BrainStorm made as a company in 2020. The many scientific and corporate milestones we have achieved this year are a testament to the talent and unwavering commitment of our employees, partners and investigators. I deeply appreciate the work they ve done, and their ability to execute in this challenging COVID environment. I want to thank especially the patients and caregivers, who showed a steadfast dedication to our clinical trials despite the pandemic. We remain committed to bringing Nu ....

United States , France General , Jacob Frenkel , Corey Davis , Chaim Lebovits , Cell Therapeutics Inc , Brainstorm Cell Therapeutics Inc , Alzheimer Center Amsterdam , Drug Administration , Rapid Reshore Development , Brain Research Centers , Prnewswire Brainstorm Cell Therapeutics Inc , Access Program , Storm Cell Therapeutics , Chief Executive Officer , Valued Shareholders , United States Food , Expanded Access Program , Current Good Manufacturing Practice , Rapid Reshore , Tel Aviv Sourasky Medical Center , Ichilov Hospital , Tel Aviv , David Setboun , Chief Operating Officer , Stacy Lindborg ,